Elaia has closed its third deep tech seed fund (DTS3) at €134 million, double the size of its previous deep tech seed funds.

The fund is developed in partnership with leading European research institutions, including PSL, INRIA, CNRS, the Barcelona Supercomputing Centre, and the Max Planck Foundation.

Investments

DTS3 will invest between €1 million and €13 million in pre-seed and seed-stage B2B startups across Europe, partnering with founders at the earliest stages. Since inception, DTS3 has backed companies with global ambition addressing fundamental bottlenecks in next-generation infrastructure.

Companies already funded include:

  • Proxima Fusion (Germany): Stellarator-based fusion power plants to provide clean, safe, and limitless baseload energy.
  • GetVocal (France): Fully auditable conversational AI agents for enterprise customer support.
  • Biophta (France): A topical ophthalmic insert to replace daily eye drops and invasive injections for conditions like glaucoma and macular edema.

Future outlook

With 11 investments completed, DTS3 will continue deploying capital throughout 2026 across three core pillars: the future of computing (AI, cybersecurity, semiconductor/photonics, quantum), the future of industry (physical AI, robotics, material, energy), and the future of life sciences (biotech, digital health, medical devices).